|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Farnesyltransferase inhibitors as anticancer agents显示文摘 | Haluska P Dy G K Adjei A A | 2002 | Eur J Cancer2002，38，13： | 1 |
| 2 | Response of B-type natriuretic peptide to exercise in hypertensive patients with suspected diastolic heart failure: correlation with cardiac function, hemodynamics, and workload 显示文摘 | MOTYRAM P M HALUSKA B A MARWICK T H | 2004 | Am Heart J2004，148，2： | 1 |
| 3 | In vitro and in vivo antitumor effects of the dual insulin-like growth facto~I/ insulin receptor inhibitor, BMS-554417显示文摘 | Haluska P Carboni JM Loegering DA | 2006 | Anticancer Res2006，66，28： | 1 |
| 4 | Influence of left ventricular size and hemodynamics on the systolic longitudinal myocardial Doppler velocity response to stress显示文摘 | Cain P Napier S Haluska B | 2002 | Am Heart J2002，143，1： | 1 |
| 5 | HER receptor signaling confers resistance to the insulin-like growth factor-Ⅰ receptor inhibitor,BMS-536924显示文摘 | Haluska P Carboni JM Teneyck C Yu C | | 0，，： | 1 |
| 6 | The insulin-like growth factor system in cancer显示文摘 | Weroha S J Haluska P | 2012 | Endocrinol Metab Clin North Am2012，41，2： | 1 |
| 7 | The insulin-like growth factor system in cancer 显示文摘 | WEROHA SJ HALUSKA P | 2012 | Endocrinol Metab Clin North Am2012，41，2： | 1 |
| 8 | Cancer and pregnancy: parallels in growth, invasion, and immune modulation and implications for cancer therapeutic agents 显示文摘 | HOLTAN S G CREEDON D J HALUSKA P | 2009 | Mayo Clin Proc2009，84，11： | 1 |
| 9 | Phase I dose escalation study of the anti-IGF-1R monoclonal antibody CP-751,871 in patients with refractory solid tumors显示文摘 | Haluska P Shaw H Batzel GN | 2007 | J Clin Oncol2007，25，24： | 1 |
| 10 | Phase Ⅰ dose escalation study of the anti insulin-like growth factor-I receptor monoclonal antibody CP-751,871 in patients with refractory solid tumors显示文摘 | HALUSKA P SHAW H M BATZEL G N | 2007 | Clin Cancer Res2007，13，4： | 1 |
| 11 | Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitu- mumab in patients with refractory adrenoeortieal carcinoma 显示文摘 | Haluska P Worden F Olmos D | 2010 | Cancer Chemother Pharmacol2010，65，： | 1 |
| 12 | Intrathecal metastases causing conus medullaris syndrome显示文摘 | Liang JJ Kizilbash SH Haluska P | 2014 | QJM2014，107，1： | 1 |
| 13 | Prioritizing therapeutic targets using patient-derived xenograft models显示文摘 | Lodhia KA Hadley A Haluska P | 2015 | Biochim Bio phys Acta2015，1855，2： | 1 |
| 14 | Can we unlock the potential of IGF-1R inhibition in cancer therapy 显示文摘 | King H Aleksic T Haluska P | 2014 | Cancer Treat Rev2014，40，9： | 1 |
| 15 | PLD-Assisted VLS growth of aligned ferrite nanorods,nanowires,and nanobelts-synthesis,and properties显示文摘 | Morber J R Ding Y Haluska M S Li Y Liu J P Wang Z L Snyder R L | | 0，，43： | 1 |
| 16 | The insulin-like growth factor system in cancer显示文摘 | Weroha SJ Haluska P | 2012 | Endocrinol Metab Clin North Am2012，41，2： | 1 |
| 17 | The insulin-like growth factor system in cancer 显示文摘 | Weroha SJ Haluska P | 2012 | Endocrlnol Metab Clin North Am2012，41，2： | 1 |
| 18 | In vitro and in vivo antitumor effects of the dual insulin-like growth factor-1/insulin receptor inhibitor, BMS-554417显示文摘 | Haluska P Carboni JM Loegering DA | 2006 | Cancer Res2006，66，1： | 1 |
| 19 | Expression of insulin receptor isoform A and insulin-like growth fac- tor-1 receptor in human acute myelogenous leukemia:ef- fect of the dual-receptor inhibitor BMS-536924 in vitro 显示文摘 | Wahner HAE Haluska P Schneider PA | 2009 | Cancer Res2009，69，19： | 1 |
| 20 | IGF-1receptor inhibitors in clinical trials-early lessons显示文摘 | Weroha SJ Haluska P | 2008 | J Mammary Gland Biol Neoplasia2008，13，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员